16 Apr 2018

Decision in the case of Elizaveta Koklina


[PressRelease]

A decision has been issued under the Tennis Anti-Doping Programme (the "Programme") that Elizaveta Koklina has committed an Anti-Doping Rule Violation under Article 2.1.

The decision imposed a period of ineligibility of twelve months, commencing on 23 October 2017.

Ms. Koklina, a 16-year-old player from Russia, provided a urine sample on 23 October 2017 in association with her participation in the Republican Girls ITF Women's Pro Circuit event held in Istanbul, Turkey. That sample was sent to the World Anti-Doping Agency (“WADA”) accredited laboratory in Montreal, Canada for analysis, and was found to contain Furosemide and Torasemide. Furosemide and Torasemide are Specified substances under category S5 (diuretics and masking agents) of the 2017 WADA Prohibited List, and therefore are also prohibited under the Programme.

Ms. Koklina was charged with an Anti-Doping Rule Violation under Article 2.1 of the Programme (presence of a Prohibited Substance in a Player’s Sample) and promptly admitted her violation. Ms. Koklina’s account of how the Furosemide and Torasemide got into her system was accepted and it was determined that she bears No Significant Fault or Negligence for the violation within the meaning of Programme Article 10.5.1. The Programme provides for the start date of the period of ineligibility to be back-dated due to the prompt admission. Therefore, the start of the ban is back-dated to the date of sample collection (23 October 2017) pursuant to Programme Article 10.10.3(b).

This is Ms. Koklina’s first Anti-Doping Rule Violation. The decision determines that (1) Ms. Koklina has committed a violation of the Programme; (2) she must serve a period of ineligibility of twelve months; and (3) that period of ineligibility is back-dated to start on 23 October 2017 and so ending at midnight on 22 October 2018. In accordance with Programme article 9.1, the points and prize money obtained by Ms. Koklina at the Istanbul event are disqualified. The full decision can be found below.

LATEST NEWS